HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tibor Keler Selected Research

flt3 ligand protein (flt3 ligand)

10/2020A Critical Role of CD40 and CD70 Signaling in Conventional Type 1 Dendritic Cells in Expansion and Antitumor Efficacy of Adoptively Transferred Tumor-Specific T Cells.
11/2019Flt3L-Mediated Expansion of Plasmacytoid Dendritic Cells Suppresses HIV Infection in Humanized Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tibor Keler Research Topics

Disease

42Neoplasms (Cancer)
09/2023 - 03/2004
9Melanoma (Melanoma, Malignant)
01/2022 - 12/2003
5Lymphoma (Lymphomas)
10/2020 - 11/2003
3Breast Neoplasms (Breast Cancer)
01/2022 - 03/2012
3Triple Negative Breast Neoplasms
01/2022 - 11/2017
3Hodgkin Disease (Hodgkin's Disease)
12/2020 - 11/2003
3Carcinoma (Carcinomatosis)
12/2020 - 03/2004
3Glioblastoma (Glioblastoma Multiforme)
01/2020 - 06/2015
3Infections
02/2017 - 10/2010
2Fatigue
12/2020 - 10/2017
2Renal Cell Carcinoma (Grawitz Tumor)
12/2020 - 12/2016
2Neoplasm Metastasis (Metastasis)
11/2017 - 11/2014
2Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
07/2007 - 11/2003
2Communicable Diseases (Infectious Diseases)
04/2005 - 12/2004
2Autoimmune Diseases (Autoimmune Disease)
04/2005 - 12/2004
1Obesity
02/2024
1Glioma (Gliomas)
09/2023
1Retinal Degeneration
01/2022
1Hematologic Neoplasms (Hematological Malignancy)
12/2020
1HIV Infections (HIV Infection)
11/2019
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2019
1Myocardial Infarction
01/2018
1Tetanus
01/2018
1Thrombocytopenia (Thrombopenia)
10/2017
1Pulmonary Embolism
10/2017
1Headache (Headaches)
10/2017
1Adenocarcinoma
12/2016
1Leukemia
07/2012
1Urinary Bladder Neoplasms (Bladder Cancer)
06/2011
1Testicular Neoplasms (Testicular Cancer)
01/2011
1Malaria
10/2010
1Ovarian Neoplasms (Ovarian Cancer)
09/2008
1Body Weight (Weight, Body)
10/2006

Drug/Important Bio-Agent (IBA)

15VaccinesIBA
09/2023 - 12/2003
13Monoclonal AntibodiesIBA
01/2018 - 11/2003
11varlilumabIBA
09/2023 - 07/2012
9AntigensIBA
01/2019 - 03/2004
8Proteins (Proteins, Gene)FDA Link
11/2017 - 03/2004
7AntibodiesIBA
10/2020 - 04/2005
6Neoplasm Antigens (Tumor Antigens)IBA
03/2012 - 03/2004
5glembatumumab vedotinIBA
01/2022 - 11/2014
5Immunoconjugates (Immunoconjugate)IBA
12/2020 - 11/2014
4Glycoproteins (Glycoprotein)IBA
01/2022 - 11/2014
4Mannose ReceptorIBA
06/2011 - 03/2004
3Immunoglobulins (Immunoglobulin)IBA
12/2020 - 07/2007
3AutoantigensIBA
10/2020 - 06/2005
3rindopepimutIBA
01/2020 - 06/2015
3epidermal growth factor receptor VIIIIBA
01/2020 - 06/2015
3EpitopesIBA
01/2018 - 03/2004
3Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
07/2011 - 03/2004
3Cancer VaccinesIBA
07/2011 - 03/2004
2Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
02/2024 - 07/2012
2flt3 ligand protein (flt3 ligand)IBA
10/2020 - 11/2019
2Immune Checkpoint InhibitorsIBA
10/2020 - 04/2014
2keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA
01/2020 - 10/2017
2Peptides (Polypeptides)IBA
01/2018 - 02/2005
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
10/2017 - 06/2011
2Temozolomide (Temodar)FDA LinkGeneric
10/2017 - 06/2015
2Toll-Like Receptor AgonistsIBA
04/2014 - 06/2011
2resiquimodIBA
04/2014 - 06/2011
2Toll-Like Receptors (Toll-Like Receptor)IBA
04/2014 - 07/2011
2poly ICLCIBA
04/2014 - 06/2011
2CDX 1307IBA
07/2011 - 06/2011
2CytokinesIBA
09/2008 - 02/2006
1IMA950IBA
09/2023
1Retinal Pigments (Pigments, Visual)IBA
01/2022
1NivolumabIBA
01/2022
1c-Mer Tyrosine KinaseIBA
01/2022
1Mucin-1 (CA 15-3 Antigen)IBA
12/2020
1Bevacizumab (Avastin)FDA Link
01/2020
1Epidermal Growth Factor (EGF)IBA
01/2020
1chenodeoxycholate sulfate conjugate (CDCS)IBA
01/2018
1OVA-8IBA
01/2018
1OvalbuminIBA
01/2018
1Protein Subunit VaccinesIBA
01/2018
1Immunoglobulin G (IgG)IBA
12/2017
1Polysaccharides (Glycans)IBA
02/2017
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
12/2016
1Differentiation AntigensIBA
12/2016
1ErbB Receptors (EGF Receptor)IBA
06/2015
1AnthracyclinesIBA
11/2014
1Capecitabine (Xeloda)FDA Link
11/2014
1taxaneIBA
11/2014
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
07/2012
1MesothelinIBA
09/2009
1cadherin 5IBA
09/2008
1Pattern Recognition ReceptorsIBA
05/2007
1LigandsIBA
01/2007
1Neutralizing AntibodiesIBA
10/2006
1anthrax toxin (anthrax lethal factor)IBA
10/2006

Therapy/Procedure

13Therapeutics
01/2022 - 10/2006
12Immunotherapy
09/2023 - 11/2003
4Drug Therapy (Chemotherapy)
10/2017 - 09/2008
1Investigational Therapies (Experimental Therapy)
01/2022
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2022
1Radiotherapy
10/2020
1Immunomodulation
10/2020
1Intradermal Injections
10/2017
1Subcutaneous Injections
12/2016
1Intramuscular Injections
10/2006